Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines
- PMID: 9498756
Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines
Abstract
Costimulation was originally defined and characterized during primary T cell activation. The signaling events that regulate subsequent antigen encounters by T cells are less well defined. In this study we examined the role of CD30 in T cell activation and defined factors that regulate expression of CD30 on T cells. We demonstrate that CD30 expression is restricted to activated T cells and regulated by CD28 signal transduction. In contrast to CD28-expressing TCR Tg cells, CD28-deficient TCR Tg cells did not express CD30 when cultured with peptide and APCs. However, rIL-4 reconstituted CD30 expression on CD28-deficient TCR Tg cells. Blockade of CD28 interactions or depletion of IL-4 inhibited the induction of CD30, suggesting that both CD28 and IL-4 play important roles in the induction of CD30 expression on wild-type cells. However, CD28 signaling did not up-regulate CD30 expression solely through its ability to augment IL-4 production because IL-4-deficient T cells stimulated with anti-CD3 and anti-CD28 expressed CD30. Induction of CD30 in the absence of IL-4 was not due to the IL-4-related cytokine IL-13. CD30, when expressed on an activated T cell, can act as a signal transducing receptor that enhances the proliferation of T cells responding to CD3 crosslinking. Collectively, the data suggest that T cell expression of CD30 is dependent on the presence of CD28 costimulatory signals or exogenous IL-4 during primary T cell activation. Once expressed on the cell surface, CD30 can serve as a positive regulator of mature T cell function.
Similar articles
-
CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.J Immunol. 1999 Aug 1;163(3):1133-42. J Immunol. 1999. PMID: 10415007
-
CD28 costimulation promotes the production of Th2 cytokines.J Immunol. 1997 Jan 15;158(2):658-65. J Immunol. 1997. PMID: 8992981
-
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.Cancer Res. 2001 Mar 1;61(5):1976-82. Cancer Res. 2001. PMID: 11280755
-
Gaining insights into the ontogeny and activation of T cells through the use of gene-targeted mutant mice.J Inflamm. 1995;45(2):79-84. J Inflamm. 1995. PMID: 7583360 Review.
-
Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor.Semin Immunol. 1993 Oct;5(5):319-26. doi: 10.1006/smim.1993.1038. Semin Immunol. 1993. PMID: 8260648 Review.
Cited by
-
The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.Clin Exp Immunol. 2011 May;164(2):145-57. doi: 10.1111/j.1365-2249.2011.04375.x. Epub 2011 Mar 14. Clin Exp Immunol. 2011. PMID: 21401577 Free PMC article.
-
Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.J Immunol. 2000 Jul 15;165(2):786-94. doi: 10.4049/jimmunol.165.2.786. J Immunol. 2000. PMID: 10878352 Free PMC article.
-
Human embryonal epithelial cells of the developing small intestinal crypts can express the Hodgkin-cell associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.Theor Biol Med Model. 2005 Jan 11;2:1. doi: 10.1186/1742-4682-2-1. Theor Biol Med Model. 2005. PMID: 15644135 Free PMC article.
-
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.PLoS Pathog. 2018 Feb 22;14(2):e1006856. doi: 10.1371/journal.ppat.1006856. eCollection 2018 Feb. PLoS Pathog. 2018. PMID: 29470552 Free PMC article.
-
CD30 Is Dispensable for T-Cell Responses to Influenza Virus and Lymphocytic Choriomeningitis Virus Clone 13 but Contributes to Age-Associated T-Cell Expansion in Mice.Front Immunol. 2017 Sep 25;8:1156. doi: 10.3389/fimmu.2017.01156. eCollection 2017. Front Immunol. 2017. PMID: 28993768 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous